PHILADELPHIA (June 8, 2015) — The Fox Chase Cancer Center–Temple University Hospital Bone Marrow Transplant (BMT) Program has recently earned the prestigious Centers of Excellence designation by OptumTM, a health services and innovation company that conducts rigorous evaluations of medical centers throughout the United States.
According to its website, Optum invites "only the most experienced and statistically successful health care providers to be part of our Centers of Excellence networks." The company develops its unique evaluation criteria in conjunction with a national panel of industry experts and practitioners. Each year, the company sends a survey to the medical centers and programs being considered for its Centers of Excellence networks. Upon receipt of a completed evaluation, Optum conducts a detailed analysis of the program's responses to both clinical and administrative components and compares the responses to evaluation criteria.
"Our team always strives for the highest standards of patient care and safety, so we are extremely proud of the BMT program's new Centers of Excellence designation," said Henry C. Fung, MD, FRCPE, vice chair of hematology at Fox Chase and director of the BMT program.
The Fox Chase Cancer Center–Temple University Hospital BMT Program has performed more than 1,500 transplants to date for patients with leukemia, lymphoma, multiple myeloma, aplastic anemia and other disorders. In 2000, Temple University Hospital's Bone Marrow Transplant Program relocated to the campus of Jeanes Hospital, a member of the Temple University Health System, in conjunction with a formal affiliation with Fox Chase Cancer Center (which is located adjacent to Jeanes).